title: Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis: Report of two cases with hyperglycemic ketoacidosis in type 1 diabetes.
authors.affiliation: Internal Medicine Department, Providence Hospital, Washington, DC, USA.
authors.forename: Hadi
authors.initials: H
authors.lastname: Harati
authors.affiliation: Internal Medicine Department, Providence Hospital, Washington, DC, USA.
authors.forename: Vandhna
authors.initials: V
authors.lastname: Sharma
authors.affiliation: Internal Medicine Department, Providence Hospital, Washington, DC, USA.
authors.forename: Abbas
authors.initials: A
authors.lastname: Motazedi
mesh_terms: D000328:Adult; D000068896:Canagliflozin / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D007004:Hypoglycemic Agents; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D000068896:Canagliflozin